Objective: To monitor cochlear function by extra- and intracochlear electrocochleography (ECoG) during and after cochlear implantation and thereby to enhance the understanding of changes in cochlear function following cochlear implantation surgery. Methods: ECoG responses to acoustic stimuli of 250, 500 and 1,000 Hz were recorded in 9 cochlear implant recipients with presurgical residual hearing. During surgery extracochlear ECoG recordings were performed before and after insertion of the cochlear implant electrode array. After insertion of the electrode array, intracochlear ECoG recordings were conducted using intracochlear electrode contacts as recording electrodes. Intracochlear ECoG recordings were performed up to 6 months after implantation. ECoG findings were correlated with findings from audiometric tests. Results: Extra- and intracochlear ECoG responses could be recorded in all subjects. Extracochlear ECoG recordings during surgery showed moderate changes. Loss or reduction of the ECoG signal at all three frequencies did not occur during cochlear implantation. During the first week following surgery, conductive hearing loss, due to middle ear effusion, led to a decrease in intracochlear ECoG signal amplitudes. This was not attributable to changes of cochlear function. All persistent reductions in ECoG response magnitude after normalization of the tympanogram occurred during the first week following implantation. Thresholds of ECoG signals were at or below hearing thresholds in all cases. Conclusion: Gross intracochlear trauma during surgery appears to be rare. In the early postoperative phase the ability to assess cochlear status by ECoG recordings was limited due to the regular occurrence of middle ear effusion. Still, intracochlear ECoG along with tympanogram recordings suggests that any changes of low-frequency cochlear function occur mainly during the first week after cochlear implantation. ECoG seems to be a promising tool to objectively assess changes in cochlear function in cochlear implant recipients and may allow further insight into the mechanisms underlying the loss of residual hearing.

Keywords:
Electrocochleography, Intracochlear electrocochleography, Cochlear implantation, Hearing preservation
1.
Adunka OF, Mlot S, Suberman TA, Campbell AP, Surowitz J, Buchman CA, Fitzpatrick DC: Intracochlear recordings of electrophysiological parameters indicating cochlear damage. Otol Neurotol 2010;31:1233-1241.
2.
Ahmad FI, Choudhury B, De Mason CE, Adunka OF, Finley CC, Fitzpatrick DC: Detection of intracochlear damage during cochlear implant electrode insertion using extracochlear measurements in the gerbil. Laryngoscope 2012;122:636-644.
3.
Anagiotos A, Hamdan N, Lang-Roth R, Gostian AO, Luers JC, Huttenbrink KB, Beutner D: Young age is a positive prognostic factor for residual hearing preservation in conventional cochlear implantation. Otol Neurotol 2015;36:28-33.
4.
Balkany TJ, Connell SS, Hodges AV, Payne SL, Telischi FF, Eshraghi AA, Angeli SI, Germani R, Messiah S, Arheart KL: Conservation of residual acoustic hearing after cochlear implantation. Otol Neurotol 2006;27:1083-1088.
5.
Calloway NH, Fitzpatrick DC, Campbell AP, Iseli C, Pulver S, Buchman CA, Adunka OF: Intracochlear electrocochleography during cochlear implantation. Otol Neurotol 2014;35:1451-1457.
6.
Campbell AP, Suberman TA, Buchman CA, Fitzpatrick DC, Adunka OF: Correlation of early auditory potentials and intracochlear electrode insertion properties: an animal model featuring near real-time monitoring. Otol Neurotol 2010;31:1391-1398.
7.
Campbell L, Kaicer A, Briggs R, O'Leary S: Cochlear response telemetry: intracochlear electrocochleography via cochlear implant neural response telemetry pilot study results. Otol Neurotol 2015;36:399-405.
8.
Carlson ML, Driscoll CL, Gifford RH, Service GJ, Tombers NM, Hughes-Borst BJ, Neff BA, Beatty CW: Implications of minimizing trauma during conventional cochlear implantation. Otol Neurotol 2011;32:962-968.
9.
Choudhury B, Adunka OF, Awan O, Pike JM, Buchman CA, Fitzpatrick DC: Electrophysiologic consequences of flexible electrode insertions in gerbils with noise-induced hearing loss. Otol Neurotol 2014;35:519-525.
10.
Choudhury B, Adunka OF, Demason CE, Ahmad FI, Buchman CA, Fitzpatrick DC: Detection of intracochlear damage with cochlear implantation in a gerbil model of hearing loss. Otol Neurotol 2011;32:1370-1378.
11.
Choudhury B, Fitzpatrick DC, Buchman CA, Wei BP, Dillon MT, He S, Adunka OF: Intraoperative round window recordings to acoustic stimuli from cochlear implant patients. Otol Neurotol 2012;33:1507-1515.
12.
Dalbert A, Sim JH, Gerig R, Pfiffner F, Roosli C, Huber A: Correlation of electrophysiological properties and hearing preservation in cochlear implant patients. Otol Neurotol 2015;36:1172-1180.
13.
DeMason C, Choudhury B, Ahmad F, Fitzpatrick DC, Wang J, Buchman CA, Adunka OF: Electrophysiological properties of cochlear implantation in the gerbil using a flexible array. Ear Hear 2012;33:534-542.
14.
Efron B, Tibshirani RJ: An Introduction to the Bootstrap. Boca Raton, Chapman & Hall/CRC, 1993.
15.
Fitzpatrick DC, Campbell AT, Choudhury B, Dillon MP, Forgues M, Buchman CA, Adunka OF: Round window electrocochleography just before cochlear implantation: relationship to word recognition outcomes in adults. Otol Neurotol 2014;35:64-71.
16.
Forgues M, Koehn HA, Dunnon AK, Pulver SH, Buchman CA, Adunka OF, Fitzpatrick DC: Distinguishing hair cell from neural potentials recorded at the round window. J Neurophysiol 2014;111:580-593.
17.
Formeister EJ, McClellan JH, Merwin WH 3rd, Iseli CE, Calloway NH, Teagle HF, Buchman CA, Adunka OF, Fitzpatrick DC: Intraoperative round window electrocochleography and speech perception outcomes in pediatric cochlear implant recipients. Ear Hear 2015;36:249-260.
18.
Gibson WP, Moffat DA, Ramsden RT: Clinical electrocochleography in the diagnosis and management of Ménière's disorder. Audiology 1977;16:389-401.
19.
Gstoettner WK, Helbig S, Maier N, Kiefer J, Radeloff A, Adunka OF: Ipsilateral electric acoustic stimulation of the auditory system: results of long-term hearing preservation. Audiol Neurotol 2006;11(suppl 1):49-56.
20.
Kel GE, Tan J, Eastwood HT, Wongprasartsuk S, O'Leary SJ: Early cochlear response and ICAM-1 expression to cochlear implantation. Otol Neurotol 2013;34:1595-1602.
21.
Kiefer J, Gstoettner W, Baumgartner W, Pok SM, Tillein J, Ye Q, von Ilberg C: Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol 2004;124:272-280.
22.
Mandala M, Colletti L, Tonoli G, Colletti V: Electrocochleography during cochlear implantation for hearing preservation. Otolaryngol Head Neck Surg 2012;146:774-781.
23.
McClellan JH, Formeister EJ, Merwin WH 3rd, Dillon MT, Calloway N, Iseli C, Buchman CA, Fitzpatrick DC, Adunka OF: Round window electrocochleography and speech perception outcomes in adult cochlear implant subjects: comparison with audiometric and biographical information. Otol Neurotol 2014;35:e245-e252.
24.
Radeloff A, Shehata-Dieler W, Scherzed A, Rak K, Harnisch W, Hagen R, Mlynski R: Intraoperative monitoring using cochlear microphonics in cochlear implant patients with residual hearing. Otol Neurotol 2012;33:348-354.
25.
Sellick P, Patuzzi R, Robertson D: Primary afferent and cochlear nucleus contributions to extracellular potentials during tone-bursts. Hear Res 2003;176:42-58.
26.
Van Emst MG, Klis SF, Smoorenburg GF: Tetraethylammonium effects on cochlear potentials in the guinea pig. Hear Res 1995;88:27-35.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.